While we did observe a slightly increased hazard (HR = 1.28) for patients carrying the 18q-loss in our cohort, the association did not reach statistical significance.
← all excerpts
Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer.
1
—
—